论文信息 - A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation - 字舞流文

A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation

R. Labianca | P. Tagliaferri | V. Catalano | G. Beretta | A. Ardizzoni | R. Berardi | S. Cascinu | M. Scartozzi | A. Sobrero | F. Pucci | S. Salvagni | A. Sobrero | E. Mari | R. Berardi | F. Pucci | F. Crocicchio | A. Ardizzoni | Stefano Cascinu | Vincenzo Catalano | S. Cascinu